The Role of Digital Health Technologies in Drug Development Proceedings of a Workshop (2020) / Chapter Skim
Currently Skimming:
Appendix C: Planning Committee Biographical Sketches
Appendix C: Planning Committee Biographical Sketches
Pages 105-112
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 105... ...
, is the interim executive director at the Digital Medicine Society, a new professional organization promoting the adoption of digital technologies for health. Previously, Ms.
|
From page 106... ...
She has provided leadership for many programs, including Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of Central Nervous System Disorders, the National Cooperative Drug/Device Discovery/Development Groups for the Treatment of Mental Disorders, and First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders.
|
From page 107... ...
She is the founder of the Health Tech Hub and directs the Small Data Lab at Cornell Tech, which develops new personal data application programming interfaces and applications for individuals to harvest the small data traces they generate daily.
|
From page 108... ...
Ginsburg has pioneered translational genomics, the development of novel diagnostics, and precision medicine, initiating programs in genome-enabled biomarker discovery, longitudinal registries with linked molecular and clinical data, biomarker-informed clinical trials, and the development of novel practice models and implementation research for the integration of genomic tools and digital health technologies into heath care delivery systems. In 1990 he was recruited to the faculty of the Harvard Medical School, where he was the director of preventive cardiology at Beth Israel Hospital and led a laboratory in applied genetics of cardiovascular diseases at Boston Children's Hospital.
|
From page 109... ...
Bennett Award for Neuropsychiatric Research, the Ziskind-Somerfeld Award for Neuropsychiatric Research, the National Alliance for Research on Schizophrenia & Depression Mood Disorders Prize, the Mogens Schou Distinguished Research Award, the American College of Neuropsychopharmacology's (ACNP's) Joel Elkes Award for Distinguished Research, the Depression and Bipolar Support Alliance Klerman Senior Distinguished Researcher Award, the Briggs Pharmacology Lectureship Award, the American Federation for Aging Research Award of Distinction, the Caring Kind Alzheimer's Disease Leadership Award, and the Global Health & the Arts Award of Recog
|
From page 110... ...
Dr. Manji has published extensively on the molecular and cellular neurobiology of severe neuropsychiatric disorders and the development of novel therapeutics, with more than 300 publications in peer-reviewed journals, including Science, Science Translational Medicine, Nature Neuroscience, Nature Reviews Neuroscience, Nature Reviews Drug Discovery, New England Journal of Medicine, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences of the United States of America, Journal of Neuroscience, JAMA Psychiatry, and Molecular Psychiatry.
|
From page 111... ...
He is board certified in internal medicine and infectious diseases and holds an academic appointment as an associate clinical professor of medicine at The George Washington University. Joyce Tung, Ph.D., joined 23andMe in 2007 and manages the 23andMe research team, which is responsible for consumer health and ancestry research and development, academic and industry collaborations, computational analyses for therapeutics, and new research methods and tools development.
|
From page 112... ...
She is a consultant to WHO on several projects and visiting faculty at the Harvard Center for Bioethics at the Harvard Medical School. In 2015 she was named a Swiss National Science Foundation Professor of Health Policy and leads the newly established Health Ethics and Policy Lab in the Department of Public Health at the University of Zurich. Her current research focus is on ethics and policy questions in personalized medicine and digital health. At the intersection of multiple fields, she relies on normative analyses and empirical methods to explore how values such as freedom of choice, participation, and privacy are affected by recent developments in personalized medicine and in digital health. She is particularly interested in the issues of ethical oversight of research uses of big data, ethical uses of big data for global health, and the ethics of citizen science.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.